Filtered By:
Source: Europace
Drug: Clopidogrel
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin
Conclusions
This analysis demonstrates that LAAC with the Watchman device is a cost-effective and cost-saving solution for stroke risk reduction in patients with non-valvular AF who are at risk for stroke but have contraindications to warfarin.
Source: Europace - June 28, 2016 Category: Cardiology Authors: Reddy, V. Y., Akehurst, R. L., Armstrong, S. O., Amorosi, S. L., Brereton, N., Hertz, D. S., Holmes, D. R. Tags: Atrial fibrillation Source Type: research
